3-Deoxy-3-acetyl abiraterone-3-ene

3-Deoxy-3-acetyl abiraterone-3-ene or 1-[17-(Pyridin-3-yl)androsta-3,5,16-trien-3-yl]ethanone, is poorly absorbed and is susceptible to hydrolysis by esterases and is an orally active inhibitor of the steroidal enzyme CYP17A1 that is used in the treatment of prostate cancer.

Additional information

Catalogue No.

VE006955

CAS No.

N/A

Molecular Formula

C26H31NO

Molecular Weight

373.5

IUPAC Name

1-[17-(Pyridin-3-yl)androsta-3, 5, 16-trien-3-yl]ethanone

References

Goldberg, Tamara, and Evangelina Berrios-Colon. “Abiraterone (Zytiga), a Novel Agent for the Management of Castration-Resistant Prostate Cancer.” Pharmacy and Therapeutics, vol. 38, no. 1, 1 Jan. 2013, pp. 23–26, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3628169/. Accessed 31 Jan. 2022.

Status

In-stock